Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 6OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Congenital Abnormalities 1Breast Neoplasms 1Blast Crisis 1

Interventions

fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 63Cyclophosphamide 59Busulfan 51Tacrolimus 46Mycophenolic Acid 46Cytarabine 44Whole-Body Irradiation 41Cyclosporine 37Methotrexate 34Antilymphocyte Serum 33Filgrastim 30Etoposide 29Radiotherapy 22Melphalan 21Flow Cytometry 21Cord Blood Stem Cell Transplantation 17Mitoxantrone 14Methylprednisolone 14Transplantation 13Granulocyte Colony-Stimulating Factor 12Idarubicin 11Clofarabine 11sargramostim 10aldesleukin 10Thiotepa 9Polymerase Chain Reaction 9Alemtuzumab 9merphos 8Therapeutics 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Congenital Abnormalities × alvocidib × Clear all
NCT00064285 2010-05-03

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

Virginia Commonwealth University

Phase 1 Completed
22 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡